# Mereo BioPharma Group plc: Form DEF 14A, filed Apr 24, 2024

- Company: [Mereo BioPharma Group plc](/companies/mreo.md) (CIK 1719714)
- Form: DEF 14A
- Filed: 2024-04-24
- Accepted by EDGAR: Apr 24, 2024, 07:30 ET
- Period: 2024-05-23
- Accession: 0001193125-24-108454
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1719714/000119312524108454/d820524ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719714/000119312524108454/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719714/000119312524108454/d820524ddef14a.htm

Filed Apr 24, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-108454. Last ingested by Listed: Nov 9, 2026, 18:01 ET. No prices; not investment advice.
